HBC Immunology shares promising results for prostate cancer co-therapy
There are around 55,100 new prostate cancer cases in the UK every year HBC Immunology (HBCI) has announced that an...
Selected News
Celltrion unveils promising dose escalation results for subcutaneous infliximab
Study reveals potential new strategy for managing inflammatory bowel disease Celltrion has announced groundbreaking results from a two-year study on...
Alleo and Ubiquigent unite to accelerate drug discovery
Partnership to harness AI for DUB-focused preclinical programmes Dundee-based Ubiquigent Limited and San Francisco’s Alleo Labs Corp have entered a...
Lundbeck to acquire Longboard Pharmaceuticals in strategic deal
Acquisition to enhance Lundbeck’s neuroscience pipeline Lundbeck has announced a significant step forward in its Focused Innovator strategy with the...
Transgene’s cancer vaccine trial shows mixed results
Phase 2 study of TG4001 shows promise in cervical cancer patients Transgene, a biotech company specializing in virus-based immunotherapies for...
Heart patient goes home hours after live-streamed valve replacement
Sheffield cardiologists demonstrate cutting-edge TAVI procedure Cardiologists at Sheffield Teaching Hospitals NHS Foundation Trust have performed a cutting-edge heart valve...
Johnson & Johnson myeloma drug recommended for NHS use
Teclistamab offers hope for patients exhausting treatment options Teclistamab (Tecvayli), a drug manufactured by Johnson & Johnson, has received a...
Purespring Therapeutics secures £80 million in Series B funding
New investment to advance gene therapies for kidney diseases Purespring Therapeutics has raised £80m in an oversubscribed Series B financing...
Sanofi launches high-dose flu vaccine in the UK
New vaccine aims to protect older adults from severe flu complications Sanofi has announced the launch of its high-dose egg-based...
Kyowa Kirin announces positive interim data for lymphoma treatment
Real-world studies show effectiveness of mogamulizumab in routine practice Kyowa Kirin International (KKI) has announced positive interim findings from three...
Astellas and AviadoBio announce exclusive gene therapy deal
AviadoBio to receive up to £1.8 billion in potential payments AviadoBio and Astellas Pharma have entered into an exclusive option...
FluoGuide submits clinical trial application for head and neck cancer treatment
Biotech company moves forward with phase 2 trial for precision cancer surgery Copenhagen-based biotech company FluoGuide A/S has announced the...
Scottish patients first in UK to access new lung cancer treatment
Scottish Medicines Consortium recommends pembrolizumab The Scottish Medicines Consortium (SMC) has recommended MSD’s KEYTRUDA (pembrolizumab) as a monotherapy for adults...
IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients
Phase 1 trial of IRL757 demonstrates good absorption and safety profile IRLAB Therapeutics AB has announced the successful completion of...
ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study
Largest real-world study demonstrates significant survival advantage In a landmark study, Johnson & Johnson has announced that ERLEADA (apalutamide) significantly...
Insilico Medicine reports positive results for idiopathic pulmonary fibrosis therapy
ISM001-055 shows promise in improving lung function among patients Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has announced...
AlzeCure’s ACD856’s effects to be presented at Alzheimer’s conference
Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid AlzeCure Pharma AB, a company specializing in drugs...
Cancer Grand Challenges launches global initiative to take on toughest problems
International think tanks to shape future of cancer research funding Cancer Grand Challenges, a pioneering initiative co-founded by Cancer Research...
AlgoTx completes pivotal phase 2 trial for ground-breaking CIPN treatment
International trial marks leap forward in chemotherapy-induced neuropathy care In a landmark announcement from Paris, AlgoTherapeutix (AlgoTx) has heralded the...
